Jad Chahoud, Chief Scientific and Innovation Officer at Orlando Health Cancer Institute, shared a post on X:
“Congrats Nabil, Indiana Hoosiers, IU Simon Comprehensive Cancer Center and the great international team leading this practice changing study!! Moving pembro-EV earlier for patients with bladder cancer.”
Other articles featuring Nabil Adra on OncoDaily.